Neurogenic or neuropathic arthropathy, often referred to as Charcot joint disease, is a degenerative condition characterized by progressive joint destruction due to loss of proprioception and sensation, primarily stemming from neurological disorders. It commonly affects individuals with diabetes mellitus, syringomyelia, or spinal cord injuries. The condition may manifest in various joints, with the foot and ankle being the most frequently involved sites, leading to significant morbidity if left untreated.

Individuals with pre-existing conditions that affect nerve function, such as diabetes, multiple sclerosis, or hereditary sensory and autonomic neuropathy, are at higher risk for developing neurogenic arthropathy. Additionally, those with prior joint trauma or surgery and patients with vascular diseases may also be predisposed. The risk is further heightened when there is impaired healing and increased weight-bearing on the affected joints.

Symptoms of neurogenic arthropathy typically include joint swelling, instability, and deformity, often accompanied by changes in skin color and temperature around the affected area. Patients may not experience pain due to the underlying sensory deficits, leading to delayed diagnosis and exacerbation of joint damage. The condition can also cause a loss of function and mobility, severely impacting the patient's quality of life.

Neurogenic arthropathy, also known as Charcot joint disease, arises from a loss of proprioception and sensation in the joints, typically due to peripheral nerve injury or central nervous system disorders such as diabetes mellitus, syringomyelia, or multiple sclerosis. The resulting unchecked trauma often leads to joint instability, deformity, and subsequent degeneration. Over time, repeated microtrauma occurs without the individual’s awareness, contributing significantly to the development of this condition.

Diagnosis of neurogenic arthropathy is primarily clinical, supported by imaging studies. Physicians take detailed patient history and conduct physical examinations to assess joint function and stability, often employing X-rays or MRI to evaluate joint destruction and changes. Electrophysiological tests may be utilized to assess nerve function and rule out other neuropathies, helping to confirm the diagnosis.

Management of neurogenic arthropathy focuses on stabilizing the affected joint and preventing further injury. Treatment options may include the use of orthopedic devices such as braces or splints, physical therapy to enhance joint function, and in some cases, surgical intervention to correct deformities or joint instability. Additionally, addressing the underlying neuropathic condition is crucial to prevent disease progression and improve the patient's quality of life.

Preventive measures for neurogenic arthropathy focus on managing underlying conditions that affect nerve function, such as strict glycemic control in diabetic patients. Regular monitoring for signs of joint problems in high-risk individuals, along with proper education on foot care and the importance of avoiding injury, are vital. Early intervention with protective footwear and orthotic devices can help prevent further joint damage and preserve mobility.